Dror Ortho-Design, Inc. 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission File No. 000-51783 NOVINT TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 85-0461778 (State or Other Jurisdiction of Incorporation or Organization) (IRS Employer Identification No.) 100 Merrick Road–Suite 400W Rockville Center , NY 11570 (Address of Principal Executive Offices) (Zip Code) ( 866 ) 298-4420 Registrant’s Telephone Number, including Area Code: Securities registered pursuant to Section 12(g) of the Act: Title of each class Common Stock, $.0001 Par Value Per Share Indicate by check whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Larger Accelerated Filer ☐ Accelerated Filer ☐ Non-Accelerated Filer ☒ Smaller Reporting Company ☒ Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐ On August 14, 2023, the Registrant had 202,308,728 shares of common stock outstanding. 1 TABLE OF CONTENTS NOVINT TECHNOLOGIES, INC. FORM 10-Q PART I. FINANCIAL INFORMATION Page Item 1. Financial Statements (unaudited) 3 Condensed Balance Sheets as of June 30, 2023 (unaudited) and December 31, 2022 3 Condensed Statements of Operations for the Three and Six Months Ended June 30, 2023 and 2022 (unaudited) 4 Condensed Statements of Stockholders’ Deficit for the Three and Six Months Ended June 30, 2023 and 2022 (unaudited) 5 Condensed Statements of Cash flows for the Six Months Ended June 30, 2023 and 2022 (unaudited) 6 Notes to Condensed Financial Statements (unaudited) 7 Item 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations 10 Item 4 Controls and Procedures 14 PART II. OTHER INFORMATION Item 1 Legal Proceedings 14 Item 1A Risk Factors 14 Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 14 Item 3 Defaults Upon Senior Securities 14 Item 5 Other Information 14 Item 6 Exhibits 15 SIGNATURES 18 2 PART I - FINANCIAL INFORMATION Item 1. Financial Statements Novint Technologies, Inc. CONDENSED BALANCE SHEETS June 30, December 31, 2023 2022 (Unaudited) ASSETS CURRENT ASSETS: Cash and cash equivalents $ 27,216 $ 55,081 Prepaid expenses 1,959 5,348 Total Current Assets 29,175 60,429 TOTAL ASSETS $ 29,175 $ 60,429 LIABILITIES AND STOCKHOLDERS’ DEFICIT CURRENT LIABILITIES: Accounts payable and accrued expenses $ 126,543 $ 101,153 Accrued royalties 708,132 683,132 Note payable – related party 50,000 — Total Current Liabilities 884,675 784,285 TOTAL LIABILITIES 884,675 784,285 STOCKHOLDERS’ DEFICIT Preferred stock, $ 0.0001 par value; 12,500,000 shares authorized, 0 shares issued and outstanding as of June 30, 2023 and December 31, 2022 — — Common stock, 0.0001 par value; 500,000,000 shares authorized, 202,308,728 shares issued and outstanding as of June 30, 2023 and December 31, 2022 20,231 20,231 Additional paid in capital 41,059,293 41,059,293 Accumulated deficit ( 41,935,024 ) ( 41,803,380 ) TOTAL STOCKHOLDERS’ DEFICIT ( 855,500 ) ( 723,856 ) TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 29,175 $ 60,429 The accompanying notes are an integral part of these financial statements. 3 Novint Technologies, Inc. CONDENSED STATEMENTS OF OPERATIONS (Unaudited) For the Three Months Ended June 30, For the Six Months Ended June 30, 2023 2022 2023 2022 Revenue $ — $ — $ — $ — Operating Expenses Professional fees 58,106 13,857 82,534 39,503 General and administrative expenses 23,159 23,001 49,110 46,655 Total Operating Expenses 81,265 36,858 131,644 86,158 Loss from operations ( 81,265 ) ( 36,858 ) ( 131,644 ) ( 86,158 ) Other expense: Interest expense, net — — — ( 14 ) Total other expense — — — ( 14 ) Loss before provision for income taxes ( 81,265 ) ( 36,858 ) ( 131,644 ) ( 86,172 ) Provision for income taxes — — — — Net loss $ ( 81,265 ) $ ( 36,858 ) $ ( 131,644 ) $ ( 86,172 ) Net loss per share Basic and Diluted $ ( 0.00 ) $ ( 0.00 ) $ ( 0.00 ) $ ( 0.00 ) Weighted-average common shares outstanding Basic and Diluted 202,308,728 202,308,728 202,308,728 202,308,728 The accompanying notes are an integral part of these financial statements. 4 Novint Technologies, Inc. CONDENSED STATEMENTS OF STOCKHOLDERS’ DEFICIT (Unaudited) Three Months Ended June 30, 2023 Additional Common Stock Paid-in Accumulated Shares Amount Capital (Deficit) Total Balances, March 31, 2023 202,308,728 $ 20,231 $ 41,059,293 $ ( 41,853,759 ) $ ( 774,235 ) Net Loss for the Three Months — — — ( 81,265 ) ( 81,265 ) Balances, June 30, 2023 202,308,728 $ 20,231 $ 41,059,293 $ ( 41,935,024 ) $ ( 855,500 ) Six Months Ended June 30, 2023 Additional Common Stock Paid-in Accumulated Shares Amount Capital (Deficit) Total Balances, December 31, 2022 202,308,728 $ 20,231 $ 41,059,293 $ ( 41,803,380 ) $ ( 723,856 ) Net Loss for the Six Months — — — ( 131,644 ) ( 131,644 ) Balances, June 30, 2023 202,308,728 $ 20,231 $ 41,059,293 $ ( 41,935,024 ) $ ( 855,500 ) Three Months Ended June 30, 2022 Additional Common Stock Paid-in Accumulated Shares Amount Capital (Deficit) Total Balances, March 31, 2022 202,308,728 $ 20,231 $ 41,059,293 $ ( 41,673,944 ) $ ( 594,420 ) Net Loss for the Three Months — — — ( 36,858 ) ( 36,858 ) Balances, June 30, 2022 202,308,728 $ 20,231 $ 41,059,293 $ ( 41,710,802 ) $ ( 631,278 ) Six Months Ended June 30, 2022 Additional Common Stock Paid-in Accumulated Shares Amount Capital (Deficit) Total Balances, December 31, 2021 202,308,728 $ 20,231 $ 41,059,293 $ ( 41,624,630 ) $ ( 545,106 ) Net Loss for the Six Months — — ( 86,172 ) ( 86,172 ) Balances, June 30, 2022 202,308,728 $ 20,231 $ 41,059,293 $ ( 41,710,802 ) $ ( 631,278 ) The accompanying notes are an integral part of these financial statements. 5 Novint Technologies, Inc. CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) For the Six Months Ended June 30, 2023 2022 Cash flows from operating activities: Net loss $ ( 131,644 ) $ ( 86,172 ) Adjustments to reconcile net loss to net cash used in operating activities: Expenses paid by related party 30,000 Changes in operating assets and liabilities: Prepaid expenses and other current assets 3,389 3,227 Accounts receivables — 1,360 Accounts payable and accrued expenses 25,390 ( 4,433 ) Accrued royalties 25,000 25,000 Net cash used in operating activities ( 47,865 ) ( 61,018 ) Cash flows from investing activities: — — Net cash provided by investing activities — — Cash flows from financing activities: Proceeds from related party promissory note 20,000 — Net cash provided by financing activities 20,000 — Net decrease in cash ( 27,865 ) ( 61,018 ) Cash and cash equivalents, beginning of year 55,081 185,935 Cash and cash equivalents, end of period $ 27,216 $ 124,917 Supplemental cash flow information: Cash paid for interest $ — $ 14 Cash paid for taxes $ 458 $ — The accompanying notes are an integral part of these financial statements. 6 NOVINT TECHNOLOGIES, INC. NOTES TO CONDENSED FINANCIAL STATEMENTS JUNE 30, 2023 (Unaudited) NOTE 1 – DESCRIPTION OF BUSINESS Novint Technologies, Inc. (the “Company” or “Novint”) was originally incorporated in the State of New Mexico in April 1999. On February 26, 2002, the Company changed its state of incorporation to Delaware by merging with Novint Technologies, Inc., a Delaware corporation. This merger was accounted for as a reorganization of the Company. Nature of Business The Company is engaged in the business of sales of 3D haptics products and equipment. Haptics refers to one’s sense of touch. The Company’s focus is in the consumer interactive computer gaming market. Additionally, the Company seeks to conduct custom project work in other related areas. The Company sells its haptics products primarily to consumers through online retail marketplaces. Going Concern and Management’s Plans These financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred recurring losses and at June 30, 2023, had an accumulated deficit of $ 41,935,024 . For the six months ended June 30, 2023, the Company sustained a net loss of $ 131,644 . These factors, among others, indicate that there is substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the date these financial statements were issued. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that may be necessary should the Company be unable to continue as a going concern. The Company’s continuation as a going concern is contingent upon its ability to obtain additional financing, and to generate revenue and cash flow to meet its obligations on a timely basis. Management intends to seek additional funding through debt or equity financing during the next twelve months to support the activities necessary to generate sales revenue and profits. We continue to monitor the COVID-19 pandemic and its effect on our business and results of operations. We cannot predict the duration, scope or severity of the COVID-19 pandemic or its future impact on our business, results of operations, cash flows and financial condition. NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Use of Estimates and Assumptions The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates and assumptions made in the preparation of the financial statements relate to accrued royalties. Actual results could differ from those estimates. Basis of Presentation The accompanying unaudited condensed financial statements were prepared using generally accepted accounting principles for interim financial information and the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all information or notes required by generally accepted accounting principles for annual financial statements and should be read in conjunction with the Company’s annual financial statements included within the Company’s Special Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on March 31, 2023. In the opinion of management, the unaudited condensed financial statements included herein contain all adjustments necessary to present fairly the Company’s financial position and the results of its operations and cash flows for the interim periods presented. Such adjustments are of a normal recurring nature. The results of operations for the three and six months ended June 30, 2023 may not be indicative of results for the full year. 7 Cash and Cash Equivalents The Company considers all highly liquid investments purchased with maturities of three months or less to be cash equivalents. The Company maintains cash balances at financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to federally insured limits. At times, balances may exceed FDIC insured limits. The Company has not experienced any losses in such accounts. Revenue and Cost Recognition In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606), and has since issued amendments thereto (collectively referred to as “ASC 606”). The core principle of ASC 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services, and the guidance defines a five-step process to achieve this core principle. The five-step process to achieve this principle is as follows: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract(s), (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract(s), and (v) recognize revenue when, or as, the entity satisfies a performance obligation. ASC 606 also mandates additional disclosure about the nature, amount, timing and uncertainty of revenues and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. The Company accounts for revenue from sales of the Falcon 3D Touch Haptic Controller (the “Falcon”) under the provisions of ASC 606. The Falcon allows the user to experience the sense of touch when using a computer, while holding its interchangeable handle. The Falcons are manufactured by an unrelated party. Revenue is recognized when products are shipped to the customer and the Company has earned the right to receive and retain reasonable assured payments for the products sold and delivered. Consequently, if revenue recognition requirements are not met, such sales will be recorded as deferred revenue until revenue recognition requirements are met. Income Taxes The Company accounts for its income taxes under the provisions of ASC Topic 740, “Income Taxes”. The method of accounting for income taxes under ASC 740 is an asset and liability method which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the Statements of Operations in the period that includes the enactment date. Fair Value of Financial Instruments The Company follows the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) for disclosures about fair value of its financial instruments and to measure the fair value of its financial instruments. The FASB ASC establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The three levels of fair value hierarchy are described below: Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The carrying amounts of the Company’s financial assets and liabilities, including cash, prepaid expenses, accounts payable, and accrued expenses and related liabilities approximate their fair values because of the short maturity of these instruments. 8 Recently Issued Accounting Pronouncements The Company has reviewed the recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC and determined that these pronouncements do not have a material impact on the Company’s current or anticipated consolidated financial statement presentation or disclosures. NOTE 3 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts payable and accrued expenses are as follows: June 30, December 31, 2023 2022 Trade payables $ 125,951 $ 100,561 Accrued expenses 592 592 Total accounts payable and accrued expenses $ 126,543 $ 101,153 NOTE 4 – ACCRUED ROYALTIES Accrued royalties relate to the Company’s licensing agreements with various parties that provided gaming software to the Company. These licensing agreements contain obligations to pay royalty fees ranging from 5 % to 50 % of either gross or net revenue, and a flat fee per end user of $ 0.50 , subject to an obligation to pay minimum annual royalties of $ 50,000 as specified in the licensing agreements. Accrued royalties as of June 30, 2023 and December 31, 2022, including unpaid annual minimum royalties, were $ 708,132 and $ 683,132 , respectively. If contested by the licensors, the Company may be required to pay these amounts, thus the Company continues to report the remaining obligation under the licensing agreements as a liability on the Company’s Balance Sheet. The Company does not believe that it remains obligated to pay these royalties. NOTE 5 – COMMITMENTS AND CONTINGENCIES From time to time in the normal course of business, the Company may be subject to routine litigation incidental to its business. Although there can be no assurances as to the ultimate disposition of any such matters, it is the opinion of management, based upon the information available at this time, that there are no matters, individually or in the aggregate, that would have a material adverse effect on the results of operations and financial condition of the Company. NOTE 6 – NOTE PAYABLE – RELATED PARTY On June 22, 2023, the Company issued and sold a promissory note with principal amount of $ 50,000 (the “AIGH Note”) to AIGH Investment Partners, LLC (“AIGH”) and received proceeds of $ 50,000 .. AIGH is controlled by the Company’s President (Principal Chief Executive Officer and Principal Chief Financial Officer). The AIGH Note is non-interest bearing and matures upon the sooner to occur of i) a financing transaction generating gross proceeds to the Company of $ 1,000,000 or greater, or ii) December 22, 2023 . The Company recognized interest expense of $ 0 and $ 0 for the six months ended June 30, 2023 and 2022, respectively. Please see below for the Company’s future minimum payments reconciled to the Notes payable – related party balance on the Balance Sheet. Years ending June 30, Maturity of Note Payable – Related Party 2024 $ 50,000 2025 — 2026 — 2027 — 2028 — Total $ 50,000 Less: debt issuance costs — Total $ 50,000 9 NOTE 7 – STOCKHOLDERS’ EQUITY Preferred Stock The Company is authorized to issue up to 12,500,000 shares of $ 0.0001 par value preferred stock. No shares of preferred stock are currently outstanding. The Board of Directors may designate the authorized but unissued shares of the Preferred Stock with such rights and privileges as the Board of Directors may determine. As such, the Board of Directors may issue preferred shares and designate the conversion, voting and other rights and preferences without notice to the shareholders and without shareholder approval. Common Stock The Company is authorized to issue 500,000,000 shares of $ 0.0001 par value common stock. All issued shares of common stock are entitled to vote on a 1 share/1 vote basis . The Company had 202,308,728 shares of common stock issued and outstanding as of June 30, 2023, and December 31, 2022. NOTE 8 – SUBSEQUENT EVENTS The Company has evaluated subsequent events through the date these financial statements were issued. In the opinion of management, there were no subsequent events that would require disclosure or adjustments to the accompanying financial statements through the date the financial statements were issued other than the following: On July 5, 2023, the Company entered into a Share Exchange Agreement (the “Exchange Agreement”) by and among the Company, Dror Ortho-Design Ltd., a company incorporated under the laws of the State of Israel (“Dror”) and the shareholders of Dror. In August of 2023 the Exchange Agreement was amended (the “Exchange Amendment”). The Exchange Agreement and Exchange Amendment together constitute the “Dror Transaction”. One closing condition of the Dror Transaction is the purchase of securities by outside investors (the “Private Placement Investors”) through a related securities purchase agreement (the “Private Placement”). The Private Placement shall be a sale and issuance of shares of the Company’s common stock and shares of the Company’s preferred stock in exchange for up to a minimum of $ 5,000,000 . Following completion of the Dror Transaction, the Dror shareholders and Private Placement Investors shall gain a majority of the Company’s voting rights and will therefor gain control of the Company. Dror shall also become a wholly owned subsidiary of the Company. As a shell company, the Company does meet the definition of a business under ASC 805 – Business Combinations and for accounting purposes the Dror Transaction is considered to be a “reverse recapitalization”. Pursuant to the terms and conditions of the Dror Transaction, the shareholders of Dror agreed to transfer 285,153 ordinary shares of Dror (the “Dror Shares”) to the Company in exchange for shares of the Company’s Preferred Stock using an exchange ratio of 36.77270 (the “Share Exchange”). Additionally, the Company agreed to assume all of Dror’s obligations under Dror’s outstanding share options (the “Dror Options”) and exchange such Dror Options for options to purchase a proportionate number of shares of common stock of the Company. The company also agreed to assume all outstanding Dror Series A-4 Warrants to purchase Dror’s ordinary shares and convert such Dror warrants into five-year warrants to acquire shares of the Company’s common stock at an exercise price of $ 0.033 per share. The Share Exchange Agreement contains certain mutual representations and warranties, covenants and indemnification provisions customary for transactions of this type. The closing of the transactions contemplated under the Share Exchange Agreement is subject to certain closing conditions described therein (the “Closing Conditions”). There is no assurance that the Closing Conditions will be satisfied. The closing of the Share Exchange is expected to occur no later than three (3) business days after the fulfillment or waiver of the Closing Conditions or on such other date and time as the parties may mutually determine. Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and analysis should be read in conjunction with the audited Financial Statements and accompanying notes thereto included in the Company’s Annual Report on Form 10-K as of and for the fiscal year ended December 31, 2022. Unless otherwise noted, all the financial information in this Report is financial information for the Company . General The Company is engaged in the business of the sale of 3D haptics products and equipment. Haptics refers to one’s sense of touch. The Company’s focus is in the consumer interactive computer gaming market. The Company seeks to conduct custom project work in other related areas The Company sells its haptics products primarily to consumers through online retail marketplaces. 10 Results of Operations for the Three Months Ended June 30, 2023 and 2022 Revenues Three months ended June 30, 2023 2022 Change Revenue $ — $ — $ — The Company recorded revenue of $0 and $0 for the three-month period ended June 30, 2023 and June 30, 2022. The Company expects to continue to incur significant expenses and operating losses for the foreseeable future. The Company’s net losses may fluctuate significantly from quarter to quarter and year to year. Operating Expenses Three months ended June 30, 2023 2022 Change Operating Expenses $ 81,265 $ 36,858 $ 44,407 Operating expenses increased by $44,407 or 120% to $81,265 for the three months ended June 30, 2023, compared with $36,858 for the three months ended June 30, 2022. This increase was due primarily to increased professional fees related to the Company’s pursuit of a potential financing transaction. Other Expense Three months ended June 30, 2023 2022 Change Other Expense $ — $ — $ — The Company recorded other expense of $0 and $0 for the three-month period ended June 30, 2023 and June 30, 2022. Results of Operations for the Six Months Ended June 30, 2023 and 2022 Revenues Six months ended June 30, 2023 2022 Change Revenue $ — $ — $ — The Company recorded revenue of $0 and $0 for the three-month period ended June 30, 2023 and June 30, 2022. The Company expects to continue to incur significant expenses and operating losses for the foreseeable future. The Company’s net losses may fluctuate significantly from quarter to quarter and year to year. Operating Expenses Six months ended June 30, 2023 2022 Change Operating Expenses $ 131,644 $ 86,158 $ 45,486 Operating expenses increased by $45,486 or 53% to $131,644 for the six months ended June 30, 2023, compared with $86,158 for the six months ended June 30, 2022. This increase was due primarily to increased professional fees related to the Company’s pursuit of a potential financing transaction. 11 Other Expense Six months ended June 30, 2023 2022 Change Other Expense $ — $ (14 ) $ (14 ) Other expense decreased by $14 or 100% to $0 during the six months ended June 30, 2023 compared with $0 during the six months ended June 30, 2022. Other expense for the six months ended June 30, 2022 consisted of interest expense related to finance charges on credit cards. Liquidity and Capital Resources The following table summarizes select balance sheet and working capital amounts as of June 30, 2023 and December 31, 2022: As of As of June 30, December 31, Change 2023 2022 Increase (Decrease) Cash $ 27,216 $ 55,081 $ (27,865 ) Working capital deficit $ (855,500 ) $ (723,856 ) $ (131,644 ) The Company had a stockholders’ deficit of $41,935,024 and $41,803,380 at June 30, 2023 and December 31, 2022, respectively. Net loss for the six months ended June 30, 2023 and 2022 was $131,644 and $86,172, respectively. Net cash used in operating activities was $47,865 and $61,018 for the six months ended June 30, 2023 and 2022, respectively. Operations since inception have been funded primarily with the proceeds from equity and debt offerings. As of June 30, 2023, the Company had cash of $27,216. The Company’s management has evaluated whether there is substantial doubt about the Company’s ability to continue as a going concern and has determined that substantial doubt existed as of the date of this filing. This determination was based on the following factors: (i) the Company’s available cash as of the date of this filing will not be sufficient to fund its anticipated level of operations for the next 12 months; (ii) the Company has incurred recurring losses and at June 30, 2023, had an accumulated deficit of $41,935,024; (iii) the Company sustained an operating loss of $131,644 for the six months ended June 30, 2023; and (iv) if the Company fails to obtain the needed capital, it will be forced to delay, scale back, or eliminate some or all of its programs or perhaps cease operations. In the opinion of management, these factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern. There is no assurance that the Company will be successful in any capital-raising efforts that it may undertake to fund operations during 2022. The Company anticipates that it will continue to issue equity and/or debt securities as a source of liquidity, until it begins to generate positive cash flow to support its operations. Any future sales of securities to finance operations will dilute existing stockholders’ ownership. The Company cannot guarantee when or if it will generate positive cash flow. The audit report prepared by the Company’s independent registered public accounting firm relating to the Company’s financial statements for the year ended December 31, 2022 included an explanatory paragraph expressing substantial doubt about the Company’s ability to continue as a going concern. Cash Flow Activities The following table summarizes the Company’s cash flows for the periods set forth below: Six months ended June 30, 2023 2022 Change Net cash used in operating activities $ (47,865 ) $ (61,018 ) $ 13,153 Net cash provided by investing activities — — — Net cash provided by financing activities 20,000 — — Net cash used in operating activities for the six months ended June 30, 2023 was $47,865 compared with net cash used in operating activities of $61,018 for the six months ended June 30, 2022. The increase in net cash used in operating activities during the six months ended June 30, 2023 was due primarily to an increase in net loss of $45,472, and partially offset by an increase of $25,390 in the change in accounts payable and accrued expenses. 12 Net cash used in operating activities for the six months ended June 30, 2023 was $47,865, representing a net loss of $131,644, partially offset by an increase of $25,390 in accounts payable and accrued expenses, an increase in accrued royalties of $25,000 and a decrease in prepaid expenses of $3,389. Net cash from financing activities for the six months ended June 30, 2023 was $20,000 representing proceeds from a related party promissory note. The remaining portion of the related party promissory note payment was $30,000 of expenses paid for by a related party, which is an operating activity. There were no cash flows from financing activities for the six months ended June 30, 2022. Effects of Inflation Management does not believe that inflation has had a material impact on the Company’s business, sales, or operating results during the periods presented. Off-Balance Sheet Arrangements The Company currently does not have any off-balance sheet arrangements or financing activities with special-purpose entities. Critical Accounting Policies and Use of Estimates Critical accounting policies are those policies which are both important to the presentation of a company’s financial condition and results and require management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. There have been no recent significant changes to our accounting policies and use of estimates during the six months ended June 30, 2023. For a further discussion of our critical accounting policies, see the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed with the SEC on March 31, 2023. Forward Looking Statements and Certain Factors That May Affect Future Results of Operations The Securities and Exchange Commission encourages companies to disclose forward-looking information so that investors can better understand a company’s future prospects and make informed investment decisions. This Quarterly Report on Form 10-Q contains such “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.All statements in this report, other than statements of historical fact, are forward-looking statements for purposes of these provisions, including any projections of earnings, revenues or other financial items, any statements of the plans and objectives of management for future operations, any statements concerning proposed new products or services, any statements regarding future economic conditions or performance, and any statements of assumptions underlying any of the foregoing. All forward-looking statements included in this report are made as of the date hereof and are based on information available to us as of such date. We assume no obligation to update any forward-looking statement. In some cases, forward-looking statements can be identified by the use of terminology such as “may,” “will,” “expects,” “plans,” “anticipates,” “intends,” “believes,” “estimates,” “potential,” or “continue,” or the negative thereof or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements contained herein are based upon reasonable assumptions at the time made, there can be no assurance that any such expectations or any forward-looking statement will prove to be correct. Our actual results will vary, and may vary materially, from those projected or assumed in the forward-looking statements. Future financial condition and results of operations, as well as any forward-looking statements, are subject to inherent risks and uncertainties, many of which we cannot predict with accuracy and some of which we might not anticipate, including, without limitation, product recalls and product liability claims; infringement of our technology or assertion that our technology infringes the rights of other parties; termination of supplier relationships, or failure of suppliers to perform; inability to successfully manage growth; delays in obtaining regulatory approvals or the failure to maintain such approvals; concentration of our revenue among a few customers, products or procedures; development of new products and technology that could render our products obsolete; market acceptance of new products; introduction of products in a timely fashion; price and product competition, availability of labor and materials, cost increases, and fluctuations in and obsolescence of inventory; volatility of the market price of our common stock; foreign currency fluctuations; changes in key personnel; work stoppage or transportation risks; integration of business acquisitions; and other factors referred to in our reports filed with the SEC, including our Registration Statement on Form 10. All subsequent forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Additional factors that may have a direct bearing on our operating results are discussed in Item 1A “Risk Factors” in our Registration Statement on Form 10. In light of these assumptions, risks and uncertainties, the results and events discussed in the forward-looking statements contained in this Quarterly Report or in any document incorporated by reference might not occur. Stockholders are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this Quarterly Report. We are not under any obligation, and we expressly disclaim any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise. All subsequent forward-looking statements attributable to us or to any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. 13 Item 4. CONTROLS AND PROCEDURES Disclosure Controls and Procedures We maintain disclosure controls and procedures (Disclosure Controls) within the meaning of Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Our Disclosure Controls are designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act, such as this Quarterly Report on Form 10-Q, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Our Disclosure Controls are also designed to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Principal Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our Disclosure Controls, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily applied its judgment in evaluating and implementing possible controls and procedures. As of the end of the period covered by this Quarterly Report on Form 10-Q, we evaluated the effectiveness of the design and operation of our Disclosure Controls, which was done under the supervision and with the participation of our management, including our Chief Executive Officer and Principal Financial Officer. Based on the evaluation of our Disclosure Controls, our Chief Executive Officer and Principal Financial Officer has concluded that, as of June 30, 2023, our Disclosure Controls were not effective due to a material weakness in the Company’s internal control over financial reporting. The ineffectiveness of our internal control over financial reporting at June 30, 2023 was due to an insufficient degree of segregation of duties among our accounting and financial reporting personnel. During the remainder of 2023, we intend to work to remediate the material weaknesses identified above, which could include the addition of accounting and financial reporting personnel and/or the engagement of accounting and personnel consultants on a limited-time basis until we add a sufficient number of personnel. Change in Internal Control over Financial Reporting Except as described above, there were no changes in our internal control over financial reporting that occurred during the three months ended June 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. PART II - OTHER INFORMATION Item 1. LEGAL PROCEEDINGS None Item 1A. RISK FACTORS Not required to be provided by smaller reporting companies. Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS. None Item 3. DEFAULTS UPON SENIOR SECURITIES None. Item 5. OTHER INFORMATION None. 14 Item 6. EXHIBITS EXHIBIT INDEX Number Description 31.1 Certification of the President and Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a), as adopted pursuant to section 302 of the Sarbanes- Oxley Act of 2002 (filed herewith). 32.1 Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes- Oxley Act of 2002 (filed herewith). 101. INS XBRL Instance Document (submitted electronically herewith). 101. SCH XBRL Taxonomy Extension Schema Document (submitted electronically herewith). 101. CAL XBRL Taxonomy Extension Calculation Linkbase Document (submitted electronically herewith). 101. LAB XBRL Taxonomy Extension Label Linkbase Document (submitted electronically herewith). 101. PRE XBRL Taxonomy Extension Presentation Linkbase Document (submitted electronically herewith). 101. DEF XBRL Taxonomy Extension Definition Linkbase Document (submitted electronically herewith). 3.1 Amend and Restated Certificate of Incorporation* 3.2 (6) Amended and Restated Bylaws* 3.3 (1) Articles of Merger* 3.4 (1) Certificate of Merger* 4.1 (1) Articles of Incorporation (See Exhibit 3.1) * 4.2 (3) Form of Common Stock Purchase Warrant, April 2006* 4.3 (7) Form of Common Stock Purchase Warrant, March 2007* 10.1 (1) License Agreement with Sandia; Amendments* 10.2 (1) Lease for 9620 San Mateo* 10.3 (1) Employment Agreement with Tom Anderson* 10.4 (1) Employment Agreement with Walter Aviles* 10.5 (10) Amended and Restated 2004 Stock Incentive Plan* 10.6 (1) Shareholders Agreement* 15 10.7 (1) Lock Up Agreement* 10.8 (1) Miscellaneous Technical Services Agreement between Aramco Services Company and Novint Technologies, Inc.* 10.9 (1) Contract Addendum between Aramco Services Company and Novint Technologies, Inc.* 10.10 (1) Amendment to Contract between Aramco Services Company and Novint Technologies, Inc.* 10.11 (1) Amendment to Contract between Aramco Services Company and Novint Technologies, Inc.* 10.12 (1) Statement of Work between Chevron Corporation and Novint Technologies, Inc.* 10.13 (1) Purchase Order from DaimlerChrylser Corporation* 10.14 (1) Purchase Order # 94059 from LockheedMartin Corporation* 10.15 (1) Purchase Order # 96996 from LockheedMartin Corporation* 10.16 (1) Purchase Order # 97860 from LockheedMartin Corporation* 10.17 (1) Purchase Order # Q50601685 from LockheedMartin Corporation* 10.18 (1) Purchase Order # QQ060592 from LockheedMartin Corporation* 10.19 (1) Purchase Order # Q50608809 from LockheedMartin Corporation* 10.20 (1) Purchase Order # 24232 from Sandia National Laboratories* 10.21 (1) Purchase Order # 27467 from Sandia National Laboratories* 10.22 (1) Purchase Order # 117339 from Sandia National Laboratories* 10.23 (1) Purchase Order # 250810 from Sandia National Laboratories* 10.24 (1) Undersea Exploration Modeling Agreement between Woods Hole Oceanographic Institute and Novint Technologies, Inc.* 10.25 (1) Purchase Order for Lunar Design, Inc. dated April 7, 2005* 10.26 (1) Sublicense Agreement between Manhattan Scientifics and Novint Technologies, Inc.* 16 10.27 (1) License and Royalty Agreement between Manhattan Scientifics and Novint Technologies, Inc.* 10.28 (1) Research Development and License Agreement between Manhattan Scientifics and Novint Technologies, Inc.* 10.29 (1) Intellectual Property License Agreement with Force Dimension LLC* 10.30 (1) Purchase Order with Lockheed Martin dated April 1, 2005* 10.31 (1) Purchase Order with Lockheed Martin dated April 4, 2005* 10.32 (1) Purchase Order with Lockheed Martin dated April 21, 2005* 10.33 (1) Purchase Order with Deakin University dated April 6, 2004* 10.34 (1) Purchase Order with Robarts Research dated September 24, 2004* 10.35 (1) Purchase Order with University of New Mexico dated March 16, 2004* 10.36 (1) Amendment to Agreement with Force Dimension Dated May 5, 2005* 10.37 (1) Amendment to contract between Aramco Services Company and Novint Technologies, Inc* 10.38 (2) Purchase Order with Lockheed Martin dated February 16, 2006* 10.39 (2) Amendment to Intellectual Property License Agreement with Force Dimension LLC dated March 9, 2006* 10.40 (2) Purchase Order with Lockheed Martin dated March 3, 2006* 10.41 (3) Form of Subscription Agreement for Securities, April 2006* 10.42 (4) Board of Directors Agreement between V. Gerald Grafe and Novint Technologies, Inc.* 10.44 (5) Manufacturing Agreement dated December 19, 2006 by and between Novint Technologies, Inc. and VTech Communications Ltd.* 10.45 (5) Novint Purchase Order 1056. (Portions of this exhibit have been omitted pursuant to a request for confidential treatment.) * 10.46 (7) Form of Unit Subscription Agreement, March 2007* 10.47 (7) Form of Investor Rights Agreement, March 2007* 10.48 (8) Amendment No. 1 to Unit Subscription Agreement dated March 2, 2007* 10.49 (8) Amendment No. 2 to Unit Subscription Agreement dated March 30, 2007* 10.50 (8) Amendment No. 1 to Investor Rights Agreement dated March 30, 2007* 10.51 (10) Purchase Order with The Falk Group, LLC dated January 16, 2007* 10.52 (11) Tournabout Intellectual Property Acquisition Agreement dated July 17, 2007* 10.53 (12) Lease Agreement dated May 29, 2007* 10.54 (12) Lease Agreement dated June 21, 2007* 14 (2) Code of Ethics* * Previously filed with the SEC as indicated, and hereby incorporated herein by reference. 17 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. August 14, 2023 NOVINT TECHNOLOGIES, INC. By: /s/ Orin Hirschman Name: Orin Hirschman Title: President (Principal Executive Officer and Principal Financial Officer) 18